Mid-Size European pharma replaced legacy system by RxLogix NextGen Safety Platform. - Rxlogix Mid-Size European pharma replaced legacy system by RxLogix NextGen Safety Platform. - Rxlogix

Mid-Size European pharma replaced legacy system by RxLogix NextGen Safety Platform.

Mid-Size European pharma replaced legacy system by RxLogix NextGen Safety Platform.

17 Dec 2025

Problem Statement​:

  • Lack of automation in case intake and case processing​
  • Multiple database and multiple applications were used within Safety Department (ARISg, Spotfire, reporting tools). Company wanted integrated platform.​
  • Performance challenges with the Aggregate report generation.​
  • Lack of automation in ICSR submissions and distribution.​
  • Expensive and inadequate vendor support for maintaining safety system.

Solution Implemented:​​

  • Replaced ArisG, IRT, Spotfire, Legacy Reporting Tool with RxLogix’s Safety-in-a-Box (PV Case Management, PV Reports & PV Central)​
  • Case form automation using ML/AI​
  • Implementation of PV Gateway for automated electronic submission​
  • Multiple Ad-hoc reports were created to streamline and provide oversight of PV operations​
  • Workflow for Global and Local Case Processing and submissions – NMPA (Chinese Agency)

400K+​Cases for Migration​ | 30+​ Adhoc & Aggregate Reports | 100+​ Concurrent Users​ | 30+​ ICSR Destinations

Milestone achieved:

  • Achieved 80-90% automation in case entry through AI/ML-powered data extraction. ​
  • Eliminated costly maintenance overhead by transitioning of multiple applications to single RxLogix’s SIAB solution​
  • Resolved performance bottlenecks in aggregate report generation​
  • Decreased dependency on vendor support ​

​​​​